{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.2:c.77G>A",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "G",
            "alt": "A",
            "position": "77"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "26"
          },
          "Description in input context": "E26K variant (p.E26K) in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005068"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin T (ThT) assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Experiments used HEK293 cells overexpressing wild-type or E26K alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.2:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E26K variant showed significantly higher ThT fluorescence (indicating increased amyloid fibril formation) compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for ThT assays."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each ThT measurement was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein-expressing cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected HEK293 cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ThT fluorescence intensity < 20% of E26K variant",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ThT fluorescence intensity ≥ 20% of E26K variant",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Transmission Electron Microscopy (TEM)",
      "Material used": {
        "Material Source": "Primary neurons",
        "Material Name": "Mouse primary neurons",
        "Description": "TEM was performed on mouse primary neurons expressing E26K or wild-type alpha-synuclein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.2:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E26K-expressing neurons exhibited dense amyloid fibrils with increased number and length compared to wild-type neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in three independent neuronal cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was imaged in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein-expressing neurons were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transfected neurons were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Quantitative analysis of fibril density using ImageJ software."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fibril density < 10 fibrils/µm²",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fibril density ≥ 10 fibrils/µm²",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}